Form 8-K - Current report:
SEC Accession No. 0000950170-24-074952
Filing Date
2024-06-18
Accepted
2024-06-18 16:43:16
Documents
12
Period of Report
2024-06-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hrtx-20240613.htm   iXBRL 8-K 124609
2 EX-3.1 hrtx-ex3_1.htm EX-3.1 9228
  Complete submission text file 0000950170-24-074952.txt   265172

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hrtx-20240613.xsd EX-101.SCH 31897
16 EXTRACTED XBRL INSTANCE DOCUMENT hrtx-20240613_htm.xml XML 4902
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 241052487
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)